Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer

Autor: Joseph, N., Dovedi, S.J., Thompson, C., Lyons, J., Kennedy, J., Elliott, T., West, C.M., Choudhury, A. *
Zdroj: In Annals of Oncology February 2016 27(2):294-299
Databáze: ScienceDirect